Cordlife Group Limited (SGX:P8A)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.1550
-0.0030 (-1.90%)
At close: May 9, 2025, 5:00 PM SGT

Cordlife Group Company Description

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally.

It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples.

The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services.

The company also provides corneal lenticule banking, gut microbiome banking, and lifestyle genetic screening services for adults.

In addition, it offers Moms Up, a mobile application that offers parenting resources, as well as sprouts for health, wellness, and lifestyle needs.

Further, the company provides medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services.

Cordlife Group Limited was incorporated in 2001 and is based in Singapore.

Cordlife Group Limited
Country Singapore
Founded 2001
Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Employees 538
CEO Pang Fai Yiu

Contact Details

Address:
1 Kim Seng Promenade
Singapore, 237994
Singapore
Phone 65 6238 0808
Website cordlife.com

Stock Details

Ticker Symbol P8A
Exchange Singapore Exchange
Fiscal Year January - December
Reporting Currency SGD
SIC Code 8090

Key Executives

Name Position
Pang Fai Yiu Chief Executive Officer
Hnin Yi Thet Chief Financial Officer